<DOC>
	<DOCNO>NCT01042691</DOCNO>
	<brief_summary>The primary goal research study determine safe dose drug oxaliplatin deliver isolated hepatic perfusion . The second goal research study determine isolate hepatic perfusion oxaliplatin improve efficacy standard hepatic arterial infusional ( HAI ) therapy floxuridine ( FUDR ) /leucovorin .</brief_summary>
	<brief_title>Isolated Liver Perfusion With Oxaliplatin</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patients include schedule undergo surgery placement hepatic arterial infusion pump HAI therapy Histologically cytologically proven measurable metastatic colorectal cancer limit parenchyma liver evidence unresectable extrahepatic disease preoperative radiological study . Limited resectable extrahepatic disease acceptable . No chemotherapy , radiotherapy , biologic therapy malignancy 4 week prior liver perfusion must recover side effect . An ECOG performance standard 0 , 1 2 24 hour prior surgery . Adequate hepatic function evidence bilirubin &lt; 2.0 mg/dL PT &lt; 2 second great upper limit normal . Age equal 18 year old great 30 kg . Platelet count great 100,000 , hematocrit &gt; 27.0 , white blood count &gt; 3000/microliter , creatinine le equal 1.5 mg/dL creatinine clearance &gt; 60 mL/min . Patients elevation hepatic transaminase secondary presence metastatic disease liver eligible . Aware neoplastic nature his/her illness , experimental nature therapy , alternative treatment , potential benefit , risk willing sign inform consent . The disease liver must consider unresectable define great three site disease liver , bilobar disease , tumor abut major vascular ductal structure make anatomic resection preservation liver function impossible . Pregnant patient nurse mother exclude due unknown effect oxaliplatin fetus newborn Patients take immunosuppressive drug chronic anticoagulation eligible . Patients active infection eligible . Patients biopsy proven cirrhosis evidence significant portal hypertension manifest ascites , esophageal varix endoscopy , radiologic study show significant collateral vessel around organ drain portal venous system exclude . Patients ischemic cardiac disease history congestive heart failure LVEF &lt; 40 % exclude . Patients COPD chronic pulmonary disease PFT 's indicate FEV &lt; 50 % predict age exclude . Patients history venoocclusive disease liver ineligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>